Cargando…

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD D...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearney, Patrick J., Zhang, Yuanxi, Tan, Yanglan, Kahuno, Elizabeth, Conklin, Tucker L., Fagan, Rita R., Pavchinskiy, Rebecca G., Shafer, Scott A., Yue, Zhenyu, Melikian, Haley E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246263/
https://www.ncbi.nlm.nih.gov/pubmed/37293098
http://dx.doi.org/10.21203/rs.3.rs-2944614/v1
_version_ 1785054999068278784
author Kearney, Patrick J.
Zhang, Yuanxi
Tan, Yanglan
Kahuno, Elizabeth
Conklin, Tucker L.
Fagan, Rita R.
Pavchinskiy, Rebecca G.
Shafer, Scott A.
Yue, Zhenyu
Melikian, Haley E.
author_facet Kearney, Patrick J.
Zhang, Yuanxi
Tan, Yanglan
Kahuno, Elizabeth
Conklin, Tucker L.
Fagan, Rita R.
Pavchinskiy, Rebecca G.
Shafer, Scott A.
Yue, Zhenyu
Melikian, Haley E.
author_sort Kearney, Patrick J.
collection PubMed
description Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression anomalies to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove a progressive motor dysfunction that was more rapid in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreases in DA release, striatal DA content, phenotypic DAergic markers, and a loss of DA neurons, with increased pSer129-alpha synuclein expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss.
format Online
Article
Text
id pubmed-10246263
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-102462632023-06-08 Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype Kearney, Patrick J. Zhang, Yuanxi Tan, Yanglan Kahuno, Elizabeth Conklin, Tucker L. Fagan, Rita R. Pavchinskiy, Rebecca G. Shafer, Scott A. Yue, Zhenyu Melikian, Haley E. Res Sq Article Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression anomalies to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove a progressive motor dysfunction that was more rapid in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreases in DA release, striatal DA content, phenotypic DAergic markers, and a loss of DA neurons, with increased pSer129-alpha synuclein expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss. American Journal Experts 2023-05-25 /pmc/articles/PMC10246263/ /pubmed/37293098 http://dx.doi.org/10.21203/rs.3.rs-2944614/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Article
Kearney, Patrick J.
Zhang, Yuanxi
Tan, Yanglan
Kahuno, Elizabeth
Conklin, Tucker L.
Fagan, Rita R.
Pavchinskiy, Rebecca G.
Shafer, Scott A.
Yue, Zhenyu
Melikian, Haley E.
Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title_full Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title_fullStr Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title_full_unstemmed Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title_short Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
title_sort rit2 silencing in dopamine neurons drives a progressive parkinsonian phenotype
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246263/
https://www.ncbi.nlm.nih.gov/pubmed/37293098
http://dx.doi.org/10.21203/rs.3.rs-2944614/v1
work_keys_str_mv AT kearneypatrickj rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT zhangyuanxi rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT tanyanglan rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT kahunoelizabeth rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT conklintuckerl rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT faganritar rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT pavchinskiyrebeccag rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT shaferscotta rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT yuezhenyu rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype
AT melikianhaleye rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype